| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |